In Vitro Activity of Tedizolid against Mycobacterium tuberculosis.

No Thumbnail Available

Date

2019-03-27

Authors

Ruiz, Pilar
Causse, Manuel
Vaquero, Manuel
Casal, Manuel

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

American Society for Microbiology
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Tedizolid is a novel oxazolidinone with activities against Gram-positive microorganisms, including mycobacteria. We studied the in vitro activity of tedizolid against 120 Mycobacterium tuberculosis strains, including susceptible, first-line-resistant, and multidrug-resistant isolates. MIC was tested using the Bactec 960 MGIT system. MIC90 and MIC50 were 0.5 and 0.25 μg/ml, respectively, in susceptible and resistant strains. Tedizolid may be an alternative in the treatment of resistant M. tuberculosis.

Description

MeSH Terms

Anti-Bacterial Agents
Drug Resistance, Multiple, Bacterial
Humans
Microbial Sensitivity Tests
Mycobacterium tuberculosis
Oxazolidinones
Tetrazoles
Tuberculosis
Tedizolid

DeCS Terms

Pruebas de sensibilidad microbiana
Técnicas in vitro
Oxazolidinonas
Farmacorresistencia bacteriana
Farmacorresistencia microbiana

CIE Terms

Keywords

Mycobacterium tuberculosis, Resistance, Tedizolid

Citation

Ruiz P, Causse M, Vaquero M, Casal M. In Vitro Activity of Tedizolid against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e01939-18